FdaApplication
ANDA 216682
Identifiers
- fda_app_no: ANDA216682
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2023-04-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEVIMELINE HYDROCHLORIDE | CEVIMELINE HYDROCHLORIDE | 30MG | CAPSULE;ORAL |
1 product